Metformin and cancer occurrence in insulin-treated type 2 diabetic patients (Q34421989)

2 August 2017

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

4

Ilaria Dicembrini

1 reference

2 August 2017

10

Niccolò Marchionni

1 reference

2 August 2017

1

Matteo Monami

1 reference

2 August 2017

12

Edoardo Mannucci

1 reference

2 August 2017

Claudia Colombi

2

1 reference

2 August 2017

Daniela Balzi

3

1 reference

2 August 2017

Stefano Giannini

5

1 reference

2 August 2017

Cecilia Melani

6

1 reference

2 August 2017

Valentina Vitale

7

1 reference

2 August 2017

Desiderio Romano

8

1 reference

2 August 2017

Alessandro Barchielli

9

1 reference

2 August 2017

Carlo Maria Rotella

11

1 reference

2 August 2017

language of work or name

English

0 references

publication date

27 October 2010

1 reference

2 August 2017

1 reference

2 August 2017

34

1 reference

2 August 2017

129-131

1 reference

2 August 2017

1

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

2 August 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Diabetes and cancer: a consensus report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Metformin and reduced risk of cancer in diabetic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Validation of a combined comorbidity index

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Metformin as an addition to conventional chemotherapy in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

Combination of insulin and metformin in the treatment of type 2 diabetes

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005459

27 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20980415

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC10-1287

1 reference

2 August 2017

1 reference

2 August 2017

1 reference